Browse life science companies in Reading, including pharmaceutical businesses, contract research and diagnostics innovators.
Specialty pharmaceuticals for Parkinson's disease and related neurological conditions
Britannia Pharmaceuticals is a UK-based specialty pharmaceutical company developing and marketing treatments for Parkinson's disease and related conditions including psychosis. The company's product range includes apomorphine-based therapies available in multiple delivery formats, alongside clozapine-based treatment…
Rapid antimicrobial susceptibility testing platform for urinary infections
Astratus is an instruments company developing a rapid antimicrobial susceptibility testing platform for clinical microbiology. Its microcapillary cassette and reader system delivers digital susceptibility results directly from urine samples in under six hours, compared to the two to three days required by standard…
Analytical testing, development and training for pharma and food sectors
Reading Scientific Services (RSSL) is a contract research organisation based at the University of Reading, providing analytical testing, product development, consultancy and training to pharmaceutical, biopharmaceutical and food and consumer goods companies. Its GMP and ISO 17025-accredited laboratories offer…
Developer and manufacturer of clinically proven prebiotic ingredients
Clasado Biosciences is a UK-based developer and manufacturer of a proprietary galactooligosaccharide prebiotic ingredient, backed by over 125 scientific publications and more than 20 clinical trials. Operating exclusively as a B2B ingredient supplier, the company serves global supplement, functional food, beverage,…
AI-powered retinal biomarker platform for early detection of eye and brain disease
Novai is a biotechnology company commercialising DARC (Detection of Apoptosing Retinal Cells), a retinal biomarker platform combining a fluorescent biologic with an AI image analysis algorithm to detect single-cell apoptosis in the retina in vivo. FDA and MHRA approved as an exploratory biomarker, DARC enables early…
VHH single-domain antibody therapeutics for companion animals and livestock
272Bio is a biotechnology company developing biotherapeutic treatments for animal health applications across livestock and companion animals. The company applies novel antibody engineering technologies, including VHH-based biologics, to create targeted and cost-effective therapies for veterinary diseases. 272Bio…
Finnish pharma company marketing and developing medicines
Orion Pharma (UK) Limited is the UK subsidiary of Orion Corporation, a Finnish pharmaceutical company. The UK entity manages commercial operations for Orion's prescription medicines portfolio across therapy areas including neurology, respiratory disease, oncology and women's health. A biologics R&D centre opened at…